BiotechTube
Home/PleoPharma/Daniel A. Cartwright
DA

Daniel A. Cartwright

Chief Financial Officer

PleoPharma

Therapeutic Areas

Central Nervous System (CNS)Substance Abuse Disorders

PleoPharma Pipeline

DrugIndicationPhase
Lead Program (Unnamed)Cannabis Use Disorder (CUD) / Cannabis Withdrawal Syndrome (CWS)Phase 2

Leadership Team at PleoPharma

GC
Ginger Constantine, M.D.
Chief Executive Officer, Co-Founder, Chairperson
JC
Jay Constantine, M.D.
Chief Medical Officer, Co-Founder, Director
SG
Shelli Graham, Ph.D.
Senior Vice President – Medical / Clinical Research
View full PleoPharma profile